Hemarthrosis clinical trials
The registry lists 21 studies for Hemarthrosis across more than 10 countries. 5 are recruiting or about to start. 7 of them are mainly about Hemarthrosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.
Get an email when these change. Save the Hemarthrosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Chulalongkorn University (2) · University of Minho (2) · University of Sao Paulo General Hospital (2) · Taipei Veterans General Hospital, Taiwan (2) · Chirec (1) · Radboud University Medical Center (1) · Dave Bernholt (1) · Spanish Society of Thrombosis and Haemostasis (1)
What is being tested here
Drugs under test in Hemarthrosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tranexamic Acid | 2 | 1 | 4 |
| Emicizumab | 1 | 1 | 1 |
| Bevacizumab | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 3 Hemarthrosis studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 1 (33%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 3 (100%) |
| 18 | 2 (67%) | 3 (100%) |
| 30 | 2 (67%) | 3 (100%) |
| 40 | 2 (67%) | 2 (67%) |
| 50 | 2 (67%) | 2 (67%) |
| 65 | 2 (67%) | 2 (67%) |
| 75 | 2 (67%) | 2 (67%) |
| 85 | 2 (67%) | 2 (67%) |
Across all 21 studies, recruiting or not: 43% stop at 75 or younger and 43% at 65; 62% take children; 0% are for women only and 33% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
- Extended Post-Operative Oral Tranexamic Acid Dosing After ACL ReconstructionOct 19, 2026NCT07880743
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- Extended Post-Operative Oral Tranexamic Acid Dosing After ACL ReconstructionNot yet recruitingNCT07880743Phase 31 country
- ATHNdataset RegistryRecruitingNCT068205151 country
- Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction.Not yet recruitingNCT07332910Phase 41 country
- Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia ARecruitingNCT06155955Phase 2/31 country
- Embolization in Hereditary CoagulopathiesRecruitingNCT05629130Not applicable1 country
- Effects of Photobiomodulation in Hemophilia Patients.CompletedNCT07579585Not applicable1 country
- A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in TaiwanActive, not recruitingNCT066843141 country
- Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic SynovitisCompletedNCT07187661Not applicable1 country
- Low-Cost Platelet-Rich Plasma for HemarthropathyCompletedNCT06543368Not applicable1 country
- Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia AActive, not recruitingNCT07439055Phase 2/31 country
- Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament ReconstructionCompletedNCT06280456Not applicable1 country
- Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®CompletedNCT030069651 country
- Changes in the Immunomodulatory Properties of Adipose Stromal Cells Due to Hemarthrosis After Knee InjuryStatus unknownNCT056873311 country
- Handheld Ultrasound (HHUS) for Home Use in HemophiliaCompletedNCT041319201 country
- COVID-19 Quarantine on Musculoskeletal Status in HemophiliaCompletedNCT044913181 country
- Ultrasonography in Hemophilic Joint Disease and Serum MarkersCompletedNCT026349181 country
- Single Time Management Diseases in Pediatric TraumatologyCompletedNCT038520951 country
- Effectiveness of Psychological Interventions in HaemophiliaCompletedNCT02870452Not applicable1 country
- Intraarticular Injection of Tranexamic Acid Reduced Postoperative Hemarthrosis in Arthroscopic Anterior Cruciate Ligament ReconstructionCompletedNCT03580018Not applicable1 country
- National Survey of People With Haemophilia in PortugalCompletedNCT028701141 country
- Viscosupplementation in Patients With Hemophilic ArthropathyCompletedNCT01748201Phase 41 country